Dr Derek S Gilchrist, Co-Founder and Chief Executive Officer
Derek is a principal investigator at the University of Glasgow and leads the scientific and technical development of TenoMiR™.
Mr. Neal L Millar, Co-Founder and Chief Medical Officer
Neal is an Academic Consultant Orthopaedic Surgeon specialising in shoulder surgery having completed fellowships in Sydney and New York and is an expert in human tendinopathy.
Prof. Iain B McInnes, Lead Medical Advisor
Iain is Director of the Institute of Infection, Immunity and Inflammation in the University of Glasgow. Iain has extensive interaction with the pharmaceutical industry and sits on the advisory boards of Pfizer; BMS; AstraZeneca; Janssen; Novartis and NovoNordisk.
Dr Simon Wheeler, Veterinary Adviser
Simon has been in the veterinary pharmaceutical industry for the last 16 years in various technical and commercial roles, including Pharmacia and Novartis Animal Health divisions, Novartis Venture Fund and Norbrook Laboratories.
Susan Kitson, Chief Research Officer
Susan has over 25 years of experience in the Life Science sector gained in an academic and industrial CRO setting where she tested novel anti-inflammatory drugs in vitro along with antibody production.
Derek is a principal investigator at the University of Glasgow and leads the scientific and technical development of TenoMiR™.
Mr. Neal L Millar, Co-Founder and Chief Medical Officer
Neal is an Academic Consultant Orthopaedic Surgeon specialising in shoulder surgery having completed fellowships in Sydney and New York and is an expert in human tendinopathy.
Prof. Iain B McInnes, Lead Medical Advisor
Iain is Director of the Institute of Infection, Immunity and Inflammation in the University of Glasgow. Iain has extensive interaction with the pharmaceutical industry and sits on the advisory boards of Pfizer; BMS; AstraZeneca; Janssen; Novartis and NovoNordisk.
Dr Simon Wheeler, Veterinary Adviser
Simon has been in the veterinary pharmaceutical industry for the last 16 years in various technical and commercial roles, including Pharmacia and Novartis Animal Health divisions, Novartis Venture Fund and Norbrook Laboratories.
Susan Kitson, Chief Research Officer
Susan has over 25 years of experience in the Life Science sector gained in an academic and industrial CRO setting where she tested novel anti-inflammatory drugs in vitro along with antibody production.
